Related Experiment Video
Updated: Jun 6, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Panel discussion: Do non-targeted effects impact the relation between microdosimetry and risk?
1Medical Research Council, Harwell, Didcot OX11 0RD, UK. d.goodhead@har.mrc.ac.uk
Radiation Protection Dosimetry
|November 26, 2010
Summary
The impact of non-targeted effects on radiation risk assessment is debated. Some argue microdosimetry is key for low-dose risk, while others deem it irrelevant for current radiation protection practices.
Area of Science:
- Radiation Biology
- Radiation Protection
- Risk Assessment
Background:
- The role of non-targeted effects in radiation risk is a subject of ongoing scientific discussion.
- Current radiation protection relies on macroscopic organ doses and epidemiological data.
- Uncertainty exists regarding the mechanisms and consequences of non-targeted effects.
Purpose of the Study:
- To summarize a panel discussion on the relevance of non-targeted effects and microdosimetry in radiation risk assessment.
- To highlight differing viewpoints on the importance of microscopic radiation characteristics for understanding risk.
- To identify knowledge gaps and fundamental issues in radiation science.
Main Methods:
- A panel discussion involving experts and symposium participants.
- Facilitated debate on the relationship between microdosimetry, non-targeted effects, and radiation risk.
- Summarization of the discussion's progression and key arguments.
Main Results:
- Divergent opinions were expressed regarding the significance of microdosimetry and non-targeted effects.
- One perspective emphasized their essential role in understanding low-dose radiation risk.
- An alternative view considered them irrelevant to established radiation protection practices.
Conclusions:
- The discussion highlighted a fundamental divergence in scientific opinion on radiation effects.
- There is a recognized need for increased scientific knowledge to address uncertainties in radiation risk assessment.
- Integrating microdosimetry and non-targeted effects into radiation protection remains a complex challenge.
More Related Videos
06:21Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
08:23An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes
Published on: December 25, 2021
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...